Related Experiment Videos
Comparative effects of ionic and nonionic iodinated low-osmolar contrast media on platelet function with the PFA-100
A D'Anglemont De Tassigny1, J M IDéE, A C Corot
1Guerbet Research Division, Aulnay-sous-Bois, France.
Investigative Radiology
|April 27, 2001
Summary
Ionic contrast media (CM) like ioxaglate show a stronger antiplatelet effect than nonionic CM (iodixanol, iohexol). This finding, observed using the PFA-100 analyzer, suggests the ioxaglic moiety is responsible, not osmolality or specific salts.
Area of Science:
- Biomedical Science
- Pharmacology
- Hematology
Background:
- Contrast media (CM) are crucial in medical imaging.
- Understanding CM effects on platelet function is vital for patient safety.
- Iodinated low-osmolar contrast media (LOCM) are widely used, with varying ionic and nonionic properties.
Purpose of the Study:
- Compare the impact of ionic (ioxaglate) and nonionic (iodixanol, iohexol) LOCM on human platelet function.
- Identify animal models that closely mimic human platelet reactivity to CM.
- Determine the specific component within ioxaglate responsible for its observed effects on platelets.
Main Methods:
- Platelet adhesion and aggregation were assessed using the PFA-100 system with collagen membrane cartridges.
- Membrane closure time (MCT) was measured to quantify antiplatelet effects.
- Blood samples from humans and various animal species were tested with different CM concentrations and ionic/nonionic controls.
Main Results:
- All tested CM significantly prolonged MCT compared to controls, indicating antiplatelet activity.
- Ionic ioxaglate demonstrated a significantly greater antiplatelet effect than nonionic iodixanol and iohexol.
- Platelet reactivity to CM was comparable across tested animal species and humans.
- The antiplatelet effect was primarily attributed to the ioxaglic moiety, independent of osmolality or specific salts (sodium/meglumine).
Conclusions:
- Ionic ioxaglate exhibits a more potent antiplatelet effect on human platelets compared to nonionic iodixanol and iohexol.
- The observed antiplatelet activity is linked to the ioxaglic molecule itself.
- Osmlality and the specific salts (sodium or meglumine) do not appear to be the primary drivers of this effect.